News

Bharat Bio completes Phase III trials of new oral cholera vaccine Hillchol
Hyderabad: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase ...
Contract Pharma3d
Shilpa Biologicals Opens Manufacturing Site for Fully Integrated ADC Development
The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...
kedglobal3d
ABL Bio lands $2.8 billion license-out deal with GSK
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-based pharmaceutical giant GSK plc in a deal expected ...
NDTV Profit on MSN4d
Bharat Biotech International's Cholera Vaccine Completes Phase III Clinical Trials
Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...